A Prospective, Randomized, Controlled Study to Evaluate the Effectiveness and Safety of CELSTAT as an Adjunct to Hemostasis for Tissue Bleeding in Cardiothoracic, General and Vascular Surgery

821391-1
Surgery
John Rousou, MD

Baystate Medical Center

759 Chestnut Street

Springfield, MA 01199

The purpose of this study is to compare the effectiveness and safety of CELSTAT versus Sergicel for treating tissue bleeding in patients undergoing cardiothoracic, general and vascular surgery.
 This study is for patients 18 years or older who are undergoing a planned (non-emergency) cardiothoracic, general or vascular surgery.
Barbara Burkott
413-794-1305